Kemnay Advisory Services’s Beam Therapeutics BEAM Stock Holding History

Kemnay Advisory Services’s Portfolio BEAM Stock Details BEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$18.8K	Buy	+789	New	+$21.9K	﹤0.01%	726

Other funds holding BEAM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Kemnay Advisory Services's BEAM Position: Q1 2026 in Review

Kemnay Advisory Services opened a new position in Beam Therapeutics (BEAM) in Q1 2026: 789 shares worth $18.8K. The stake represents ﹤0.01% of the portfolio and ranks #726 among its holdings.

251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

Kemnay Advisory Services held 789 shares of Beam Therapeutics worth $18.8K as of Q1 2026.
Beam Therapeutics was a new Kemnay Advisory Services position in Q1 2026.
Beam Therapeutics made up ﹤0.01% of Kemnay Advisory Services's portfolio in Q1 2026, its #726 holding.
251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on Kemnay Advisory Services's 13F filing for Q1 2026, filed 15 May 2026.